Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-in-human topical M528101 in healthy volunteers and atopic dermatitis subjects
NL-OMON50835Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of M528101 in atopic dermatitis (AD) (6 arms), sponsored by Maruho Co., Ltd. Primary endpoints: Safety after topical administration, Tolerability after topical administration and 1 more. Started Feb 2021; status: completed.
02
Drugs
M528101
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NL-OMON50835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50835.